Search Symbol, Name or Keyword
en
en
Quote
About
Disclosure
SKNY
0.00%
SKNY
0.00%
LIR Life Sciences Corp.
Status
Active
T2
Industry
Life Sciences
Issued & Outstanding
28,666,957
Reserved for Issuance
3,680,000
Currency
CAD
CSE Index
CSE Composite
Quote
Toggle options
Last Price
—
0.00
(0.00%)
Volume
0
Change
0.00
Bid Size
0
Bid Price
—
Ask Price
—
Ask Size
0
Prev Close
—
Open
—
Day High
—
Day Low
—
52 Week High
—
52 Week Low
—
LIR Life Sciences Corp.
Charts by
TradingView
Depth Display
Toggle options
CSE
CSE2
By Order
By Price
Toggle options
CSE
CSE2
Bid Broker
Bid Size
$
Bid Price
$
Ask Price
Ask Size
Ask Broker
Recent Trades
Toggle options
CSE
CSE2
Date/Time
$
Price
$
Change
Volume
Buyer
Seller
About
LIR Life Sciences Corp.
Listing Date
April 11, 2022
Website
lirlife.com
LIR Life Sciences Inc. is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the aim of improving accessibility and patient experience.
Contacts
Email
[email protected]
Phone
1 888-436-7772
Address
505-1505 West 2nd Avenue
Vancouver, British Columbia V6J 1H2
Canada
Transfer Agent
Endeavor Trust Corporation
Auditor
Saturna Group Chartered Professional Accountants LLP
Company Officers
CEO
Edward Mills
CFO and Corporate Secretary
Harry Nijjar
Issuer Administrator
Nicole Lacson
Contacts
Contacts
Company Officers
Company Officers